Mutations presented the fact that, as defined down below, CLL therapy is based within the existence or absence of those mutations. The existing consensus is always that, other than clonal mutations, subclonal mutations having a variant allelic frequency starting from 5 to 10% (and for that reason below the brink https://jamesx021mfq4.blogolenta.com/profile